BRAF,KITandNRASmutations and expression of c-KIT, phosphorylated extracellular signal-regulated kinase and phosphorylated AKT in Japanese melanoma patients-Reference-Cited by-同舟云学术

BRAF,KITandNRASmutations and expression of c-KIT, phosphorylated extracellular signal-regulated kinase and phosphorylated AKT in Japanese melanoma patients

Published:2015-03-13 Issue:5 Volume:42 Page:477-484
ISSN:0385-2407
Container-title:The Journal of Dermatology
language:en
Short-container-title:J Dermatol

Author:

Oyama Satomi¹,Funasaka Yoko¹,Watanabe Atsushi²,Takizawa Toshihiro³,Kawana Seiji¹,Saeki Hidehisa¹

Affiliation:

1. Department of Dermatology; Graduate School of Medicine; Nippon Medical School; Tokyo Japan

2. Department of Molecular and Medical Genetics; Graduate School of Medicine; Nippon Medical School; Tokyo Japan

3. Department of Molecular Medicine and Anatomy; Graduate School of Medicine; Nippon Medical School; Tokyo Japan

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1346-8138.12822/fullpdf

Reference43 articles.

1. Cutaneous melanoma;Eggermont;Lancet,2014

2. Fibroblast growth factors in normal and malignant melanocytes;Halaban;Ann N Y Acad Sci,1991

3. c-Kit-kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas;Funasaka;Mol Biol Cell,1992

4. The Raf/MEK/ERK pathway: new concepts of activation;Peyssonnaux;Biol Cell,2001

5. N-ras mutations in human cutaneous melanoma from sun-exposed body sites;Veer;Mol Cell Biol,1989

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Five-Year Follow-Up of POLARIS-01 Phase II Trial: Toripalimab as Salvage Monotherapy in Chinese Patients With Advanced Melanoma;The Oncologist;2024-03-28

2. BRAF V600E Mutations and Beyond: A Molecular Perspective of Melanoma from a Tertiary Cancer Referral Center of India;South Asian Journal of Cancer;2023-03-02

3. Advanced Acral Melanoma Therapies: Current Status and Future Directions;Current Treatment Options in Oncology;2022-09-20

4. Systematic review and meta‐analysis of genomic alterations in acral melanoma;Pigment Cell & Melanoma Research;2022-03-07

5. BRAF, C-KIT, and NRAS mutations correlated with different clinicopathological features: an analysis of 691 melanoma patients from a single center;Annals of Translational Medicine;2022-01